X0306 4 2021-02-23 0 0001439725 BIODESIX INC BDSX 0001697361 Hutton Scott 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 1 1 0 0 President & CEO Stock Options (Right to buy) 0.77 2021-02-23 4 A 0 8423 0 A 2029-03-21 Common Stock 8423 8423 D Stock Options (Right to buy) 0.77 2022-03-10 4 A 0 8423 0 A 2029-03-21 Common Stock 8423 16846 D Stock Options (Right to buy) 2.29 2022-03-10 4 A 0 85875 0 A 2022-03-10 2032-03-09 Common Stock 85875 85875 D On March 22, 2019, the Reporting Person was granted an option to purchase 25,269 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 8,423 shares underlying the option. On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the "Compensation Committee") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 8,423 shares underlying the option. On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 8,423 shares underlying the option. /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton 2022-03-14